510 related articles for article (PubMed ID: 12681432)
1. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
[TBL] [Abstract][Full Text] [Related]
2. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
3. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
4. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
5. Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806.
Nunn C; Schoeffter P; Langenegger D; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):1-9. PubMed ID: 12616335
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
[TBL] [Abstract][Full Text] [Related]
7. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterisation of human cerebral cortex somatostatin SRIF1 and SRIF2 receptors.
Piwko C; Thoss VS; Schüpbach E; Kummer J; Langenegger D; Probst A; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):161-7. PubMed ID: 9050007
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
Siehler S; Zupanc GK; Seuwen K; Hoyer D
Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity.
Siehler S; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):522-32. PubMed ID: 10598791
[TBL] [Abstract][Full Text] [Related]
11. Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).
Rivier JE; Hoeger C; Erchegyi J; Gulyas J; DeBoard R; Craig AG; Koerber SC; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2001 Jun; 44(13):2238-46. PubMed ID: 11405660
[TBL] [Abstract][Full Text] [Related]
12. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
Siehler S; Seuwen K; Hoyer D
Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
Thoss VS; Piwko C; Probst A; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterisation of the goldfish somatostatin sst5 receptor.
Nunn C; Feuerbach D; Lin X; Peter R; Hoyer D
Eur J Pharmacol; 2002 Feb; 436(3):173-86. PubMed ID: 11858797
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization.
Thoss VS; Piwko C; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):648-60. PubMed ID: 8738298
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
Erchegyi J; Hoeger CA; Low W; Hoyer D; Waser B; Eltschinger V; Schaer JC; Cescato R; Reubi JC; Rivier JE
J Med Chem; 2005 Jan; 48(2):507-14. PubMed ID: 15658864
[TBL] [Abstract][Full Text] [Related]
18. Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptors.
Nunn C; Rueping M; Langenegger D; Schuepbach E; Kimmerlin T; Micuch P; Hurth K; Seebach D; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):95-103. PubMed ID: 12595949
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors.
Hoyer D; Pérez J; Schoeffter P; Langenegger D; Schüpbach E; Kaupmann K; Lübbert H; Bruns C; Reubi JC
Eur J Pharmacol; 1995 Mar; 289(1):151-61. PubMed ID: 7781706
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
